Multiple signaling pathways have been implicated in this process by promoting the increased expression of EC characteristics in tumor cells, including VE-cadherin and VEGFR2 signaling, and the integrin B8-TGFβ1 axis [46,47]. The gene discussed is TGFB1; the disease is neoplasm.